Chloroquine and Hydroxychloroquine – drugs used against malaria – have raised significant controversy. Data on treatment or prophylaxis for COVID-19 is limited. Some studies have shown that these drugs may be helpful, others caution about serious side effects. This Webinar will discuss the role of randomized controlled clinical trials in developing safe and effective medications for treatment and prophylaxis of COVID-19.
Date: May 13, 8:00 AM (EST)
Click HERE to see the live recording!
YOUR tax-exempt DONATIONS of $10 to $20 will help up continue organizing more unique webinars. Donate HERE!
Dr. Phaik Yeong Cheah, PhD, Head of the Department of Bioethics and Engagement, Associate Professor of Oxford University and in Bangkok, Thailand at the Wellcome Programme
Lisa Kearns, MS, MA, Senior Research Associate in the Division of Medical Ethics at NYU Grossman School of Medicine
Isabelle Niu, MA, Journalist at Quartz based in New York
NOTE: This webinar will not offer continuing education credits
- Outline the justifications for randomized controlled trials for COVID-19
- Outline ethical issues around clinical trials in pandemics
- Provide resources for ongoing clinical trials on the use of Chloroquine, Hydroxychloroquine and other drugs for treatment and prevention of COVID-19
The Webinar is co-sponsored by Bioethics and Engagement & MORU Tropical Health Network